Squarepoint
SANA icon

Squarepoint’s Sana Biotechnology SANA Stock Holding History

Squarepoint’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.6K Sell
24,523
-93,952
-79% -$303K ﹤0.01% 4222
2026
Q1 		$341K Sell
118,475
-213,266
-64% -$840K ﹤0.01% 3608
2025
Q4 		$1.35M Buy
331,741
+109,419
+49% +$490K ﹤0.01% 2364
2025
Q3 		$789K Buy
222,322
+131,324
+144% +$475K ﹤0.01% 2875
2025
Q2 		$248K Buy
90,998
+19,773
+28% +$40.8K ﹤0.01% 3825
2025
Q1 		$120K Sell
71,225
-107,206
-60% -$300K ﹤0.01% 4171
2024
Q4 		$291K Buy
178,431
+55,625
+45% +$166K ﹤0.01% 4169
2024
Q3 		$511K Sell
122,806
-3,766
-3% -$19.8K ﹤0.01% 3072
2024
Q2 		$691K Buy
126,572
+96,348
+319% +$768K ﹤0.01% 2833
2024
Q1 		$302K Buy
30,224
+19,557
+183% +$147K ﹤0.01% 3376
2023
Q4 		$43.5K Sell
10,667
-59,981
-85% -$221K ﹤0.01% 3863
2023
Q3 		$273K Buy
70,648
+38,979
+123% +$210K ﹤0.01% 3233
2023
Q2 		$189K Sell
31,669
-139,080
-81% -$802K ﹤0.01% 3241
2023
Q1 		$558K Buy
170,749
+96,546
+130% +$386K ﹤0.01% 2240
2022
Q4 		$293K Sell
74,203
-114,952
-61% -$562K ﹤0.01% 2590
2022
Q3 		$1.14M Buy
189,155
+148,317
+363% +$1.07M 0.01% 1682
2022
Q2 		$263K Buy
+40,838
New +$260K ﹤0.01% 2352
2022
Q1 		– Sell
-11,019
Closed -$171K – 3432
2021
Q4 		$171K Buy
+11,019
New +$212K ﹤0.01% 2765

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Squarepoint's SANA Position: Q2 2026 in Review

Squarepoint reduced its Sana Biotechnology (SANA) stake by 79% in Q2 2026, selling an estimated $303K and leaving 24,523 shares worth $85.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4222.

Squarepoint first reported a position in SANA in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.35M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Squarepoint held 24,523 shares of Sana Biotechnology worth $85.6K as of Q2 2026.
  • Squarepoint sold 93,952 Sana Biotechnology shares in Q2 2026, an estimated $303K.
  • Sana Biotechnology made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4222 holding.
  • Squarepoint first reported a position in Sana Biotechnology in Q4 2021 and has held it in 18 quarters since.
  • Squarepoint's Sana Biotechnology position peaked at $1.35M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.